IP Library Granted Patent US 8,871,447
Granted Patent B2
US 8,871,447 · App. 10/527,678 · Granted Oct 28, 2014

Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence

Inventors: Rakez Kayed (Irvine, CA); Charles Glabe (Irvine, CA)
Assignee: The Regents of the University of California
A61K39/0007C07K16/18C07K16/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,871,447
App. No.
10/527,678
Granted
Oct 28, 2014
Kind
B2
Abstract

Compositions of matter that comprise one or more conformational epitopes found on amyloid peptide aggregates, antibodies to such epitopes and methods for making and using the compositions, eptitopes and/or antibodies. The invention includes synthetic or isolated compositions that contain or consist of certain conformational epitopes that are found on peptide aggregates (e.g., toxic peptide aggregates) present in human or veterinary patients who suffer from, or who are likely to develop, amyloid diseases (e.g., Alzheimer's Disease). The invention includes methods for the detection, treatment and prevention of diseases in humans or animals, using such compositions. The invention further includes antibodies which bind to the conformational epitopes as well as methods for making such antibodies and methods for the detection, treatment and prevention of diseases and/or identification of potential therapies (e.g., drug screening) using such antibodies.

Claims (20)

1. A composition comprising an isolated conformational epitope of a soluble amyloid aggregate which a) forms in a human or animal and b) contributes to amyloid disease;

said conformational epitope comprising five or more monomers, wherein the epitope is affixed to a curved or flat support surface, wherein affixation to the support surface causes the epitope to assume and be constrained in a three-dimensional conformation, wherein the three-dimensional confirmation causes the epitope to be recognized by an antibody that binds an Aβ peptide aggregate that is not a monomer, dimer, trimer, tetramer or Aβ fibril; and wherein the support surface comprises a material selected from; gold, zinc, cadmium, tin, titanium, silver, selenium, gallium, indium, arsenic, silicon, mixtures thereof and combinations thereof.

2. A composition according to claim 1 wherein the epitope composition is conformationally constrained.

3. A composition according to claim 1 wherein the composition is chemically bound to the surface.

4. A composition according to claim 1 wherein the amyloid aggregate has a molecular weight in a range of about 1 kDa to about 100,000,000 kDa.

5. A composition according to claim 1 wherein the epitope comprises an epitope of a toxic species of an amyloid aggregate.

6. A composition according to claim 1 wherein the epitope is chemically bound to the surface.

7. A composition according to claim 6 wherein the epitope comprises a C terminus, wherein the C terminus is bound to the support surface.

8. A composition according to claim 7 wherein the C terminus is bound to the surface by a carboxy thiol linkage.

9. A composition according to claim 8 wherein the surface comprises a gold surface.

10. A composition according to claim 9 wherein the gold surface comprises colloidal gold.

11. A composition according to claim 1 wherein the epitope comprises an epitope of Aβ.

12. A composition according to claim 1 wherein the epitope is coupled to gold on the support surface.

13. A composition according to claim 12 wherein the epitope comprises a C terminus, wherein the C terminus is coupled to gold on the support surface.

14. A composition according to claim 13 wherein the gold comprises colloidal gold.

15. A composition according to claim 1 wherein the surface comprises a surface of a film.

16. A composition according to claim 1 wherein the surface comprises a surface of a sheet.

17. A composition according to claim 1 wherein the surface comprises a surface of a pleated sheet.

18. A composition according to claim 1 wherein the surface comprises a surface of a protein.

19. A composition according to claim 1 wherein the epitope comprises SEQ ID NO. 2.

Assignments (2)
CONFIRMATORY LICENSE Recorded Feb 16, 2010
From: UNIVERSITY OF CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023938/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2006
From: KAYED, RAKEZ; GLABE, CHARLES
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 017265/0730 →
Continuity (2)
Provisional Application 60410069 · Sep 12, 2002
Related Publication 20060280733A1 · Dec 14, 2006